High resolution karyotyping is, typically, completed and reported to the referring physician about a week after an amnio. There are genetic probes that can be used for specific concerns that are reported within a day. Discussion of options is part of the informed consent process.
We utilize web based tracking of the entire laboratory process, so that vital information about the specimen and the test results are always available without delay. |
 |
Every patient has special concerns and preferences. Many patients will not want an amnio under any circumstances. That is their right and privelege. Usually, we do not even raise the possibility until after we have as thorough an examination as our equipment and fetal size, depth, and position will allow. All of our studies are interactive; we encourage our patients to join in our guiided tours of their babies-to-be and to participate in optimizing care withtheir own physicians and with us.
